2 hrs ago | Daily News
'Colluding' hospital supplier hit
“The... allegations of collusive tendering and market allocation made in the complaint referral against AICC were substantially correct.”
The Competition Commission slapped SA's largest supplier of hospital products, Adcock Ingram, with a R53-million fine on Friday, the highest penalty in local history for collusive behaviour. via Daily News
6 hrs ago | The Jersey Journal
Sanofi-Aventis faces Plavix challenge in Europe
Shares of French drug maker Sanofi-Aventis fell in premarket trading today after a Swiss drug maker says it expects to receive approval to sell a generic version of Sanofi's anti-clotting agent Plavix , the ... via The Jersey Journal
10 hrs ago | Huliq.com
DAYTRANA offered ADHD symptom control for 12 months
“These positive findings, along with previously presented research, reinforces that the ADHD patch is an important treatment option for children, especially those who may benefit from an ADHD medication that can accommodate their changing daily needs.”
Shire plc , the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRANA between boys and girls aged 6 to ... via Huliq.com
15 hrs ago | Local Tech Wire
Pozen's revenue forecast tops Wall Street expectations
Pozen foresees better sales for its recently approved migraine drug than Wall Street analysts. via Local Tech Wire
19 hrs ago | ClipSyndicate
VIDEO: Biotech Stocks to Watch: Amylin Pharmaceuticals, Gilead...
Amylin Pharmaceuticals Ammending Pact with Eli Lilly Concerning U.S. Marketing; Gilead Sciences CEO John Martin Takes on Additional Duties as Board Chairman; Novartis to Buy Another 214K Addtional Unregistered ... via ClipSyndicate
23 hrs ago | Reuters
Top lawmaker reprimands drugmakers over ads
“It appears that we need to enforce significant restrictions on DTC (direct-to-consumer) ads to protect American consumers from manipulative commercials designed to mislead and deceive for the profit of pharmaceutical companies”
Pharmaceutical companies need to be more responsible in touting their products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on Thursday. via Reuters
Yesterday | Globeinvestor.com
Biovail narrows focus, unveils stock buyback
Biovail Corp. will take charges of $80-million to $100-million in its next few quarters as a result of a number of changes in the company's strategy, including shutting down plants in Puerto Rico, a shift in ... via Globeinvestor.com
Yesterday | Health News Digest
Falls a Leading Cause of Injury-Related Emergency Department Visits for Infants Each Year
“As children develop -- in infancy and throughout childhood -- protective factors such as home safety measures and close parental supervision are critical in helping to prevent injuries.”
Half of the estimated 328,500 infants 12 months of age or younger who were treated for injuries in hospital emergency departments each year from 2001 to 2004 were injured as a result of a fall, according to a ... via Health News Digest
Yesterday | Pravda
ConvaTec to belong to new owners
Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments ... via Pravda
Yesterday | Journal Gazette
Chantix recommended to quit smoking despite safety concerns
“People are quitting smoking to save their lives”
The federal government's new advice to doctors for helping smokers quit recommends the drug Chantix, which has recently been linked with depression and suicidal behavior. via Journal Gazette






